img

Global Preclinical CRO Treatment Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Preclinical CRO Treatment Market Insights, Forecast to 2034

Preclinical contract research organizations (CROs) offer research and development services to pharmaceutical and biotechnology companies during the early stages of drug development, including preclinical studies and animal testing.
Market Analysis and InsightsGlobal Preclinical CRO Treatment Market
Global Preclinical CRO Treatment market is expected to reach to US$ 808.4 million in 2024, with a positive growth of %, compared with US$ 714.3 million in 2022. Backed with the increasing demand from downstream industries, Preclinical CRO Treatment industry is evaluated to reach US$ 1612.8 million in 2029. The CAGR will be 12.2% during 2024 to 2029.
The market for preclinical CRO services is driven by the demand for specialized expertise and resources in drug development and the need for efficient and cost-effective preclinical research. The market's growth is also influenced by the increasing outsourcing of preclinical studies by pharmaceutical and biotech companies.
Report Covers
This report presents an overview of global Preclinical CRO Treatment market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Preclinical CRO Treatment market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Charles River Laboratories
Laboratory Corporation of America
Envigo
Eurofins Scientific
PRA Health Science
Wuxi Apptec Co.,Ltd.
Medpace
Pharmaceutical Product Development
Paraxel
Pharmaron
Joinn Laboratories
Medicilon Inc.
Crown Bioscience
Yinuosi Bio-Technology
Segment by Type
Bioanalysis and DMPK Studies
Toxicology Testing

Segment by Application


Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Preclinical CRO Treatment introduction, etc. Preclinical CRO Treatment Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Preclinical CRO Treatment
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical CRO Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Bioanalysis and DMPK Studies
1.2.3 Toxicology Testing
1.3 Market by Application
1.3.1 Global Preclinical CRO Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Medical Device Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preclinical CRO Treatment Market Perspective (2018-2029)
2.2 Global Preclinical CRO Treatment Growth Trends by Region
2.2.1 Preclinical CRO Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Preclinical CRO Treatment Historic Market Size by Region (2018-2024)
2.2.3 Preclinical CRO Treatment Forecasted Market Size by Region (2024-2029)
2.3 Preclinical CRO Treatment Market Dynamics
2.3.1 Preclinical CRO Treatment Industry Trends
2.3.2 Preclinical CRO Treatment Market Drivers
2.3.3 Preclinical CRO Treatment Market Challenges
2.3.4 Preclinical CRO Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Preclinical CRO Treatment by Players
3.1.1 Global Preclinical CRO Treatment Revenue by Players (2018-2024)
3.1.2 Global Preclinical CRO Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Preclinical CRO Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Preclinical CRO Treatment, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Preclinical CRO Treatment Market Concentration Ratio
3.4.1 Global Preclinical CRO Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical CRO Treatment Revenue in 2022
3.5 Global Key Players of Preclinical CRO Treatment Head office and Area Served
3.6 Global Key Players of Preclinical CRO Treatment, Product and Application
3.7 Global Key Players of Preclinical CRO Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Preclinical CRO Treatment Breakdown Data by Type
4.1 Global Preclinical CRO Treatment Historic Market Size by Type (2018-2024)
4.2 Global Preclinical CRO Treatment Forecasted Market Size by Type (2024-2029)
5 Preclinical CRO Treatment Breakdown Data by Application
5.1 Global Preclinical CRO Treatment Historic Market Size by Application (2018-2024)
5.2 Global Preclinical CRO Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Preclinical CRO Treatment Market Size (2018-2029)
6.2 North America Preclinical CRO Treatment Market Size by Type
6.2.1 North America Preclinical CRO Treatment Market Size by Type (2018-2024)
6.2.2 North America Preclinical CRO Treatment Market Size by Type (2024-2029)
6.2.3 North America Preclinical CRO Treatment Market Share by Type (2018-2029)
6.3 North America Preclinical CRO Treatment Market Size by Application
6.3.1 North America Preclinical CRO Treatment Market Size by Application (2018-2024)
6.3.2 North America Preclinical CRO Treatment Market Size by Application (2024-2029)
6.3.3 North America Preclinical CRO Treatment Market Share by Application (2018-2029)
6.4 North America Preclinical CRO Treatment Market Size by Country
6.4.1 North America Preclinical CRO Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Preclinical CRO Treatment Market Size by Country (2018-2024)
6.4.3 North America Preclinical CRO Treatment Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Preclinical CRO Treatment Market Size (2018-2029)
7.2 Europe Preclinical CRO Treatment Market Size by Type
7.2.1 Europe Preclinical CRO Treatment Market Size by Type (2018-2024)
7.2.2 Europe Preclinical CRO Treatment Market Size by Type (2024-2029)
7.2.3 Europe Preclinical CRO Treatment Market Share by Type (2018-2029)
7.3 Europe Preclinical CRO Treatment Market Size by Application
7.3.1 Europe Preclinical CRO Treatment Market Size by Application (2018-2024)
7.3.2 Europe Preclinical CRO Treatment Market Size by Application (2024-2029)
7.3.3 Europe Preclinical CRO Treatment Market Share by Application (2018-2029)
7.4 Europe Preclinical CRO Treatment Market Size by Country
7.4.1 Europe Preclinical CRO Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Preclinical CRO Treatment Market Size by Country (2018-2024)
7.4.3 Europe Preclinical CRO Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Preclinical CRO Treatment Market Size (2018-2029)
8.2 China Preclinical CRO Treatment Market Size by Type
8.2.1 China Preclinical CRO Treatment Market Size by Type (2018-2024)
8.2.2 China Preclinical CRO Treatment Market Size by Type (2024-2029)
8.2.3 China Preclinical CRO Treatment Market Share by Type (2018-2029)
8.3 China Preclinical CRO Treatment Market Size by Application
8.3.1 China Preclinical CRO Treatment Market Size by Application (2018-2024)
8.3.2 China Preclinical CRO Treatment Market Size by Application (2024-2029)
8.3.3 China Preclinical CRO Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Preclinical CRO Treatment Market Size (2018-2029)
9.2 Asia Preclinical CRO Treatment Market Size by Type
9.2.1 Asia Preclinical CRO Treatment Market Size by Type (2018-2024)
9.2.2 Asia Preclinical CRO Treatment Market Size by Type (2024-2029)
9.2.3 Asia Preclinical CRO Treatment Market Share by Type (2018-2029)
9.3 Asia Preclinical CRO Treatment Market Size by Application
9.3.1 Asia Preclinical CRO Treatment Market Size by Application (2018-2024)
9.3.2 Asia Preclinical CRO Treatment Market Size by Application (2024-2029)
9.3.3 Asia Preclinical CRO Treatment Market Share by Application (2018-2029)
9.4 Asia Preclinical CRO Treatment Market Size by Region
9.4.1 Asia Preclinical CRO Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Preclinical CRO Treatment Market Size by Region (2018-2024)
9.4.3 Asia Preclinical CRO Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Preclinical CRO Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Preclinical CRO Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Preclinical CRO Treatment Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Preclinical CRO Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Preclinical CRO Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Preclinical CRO Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Preclinical CRO Treatment Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Preclinical CRO Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Preclinical CRO Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Preclinical CRO Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Preclinical CRO Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Preclinical CRO Treatment Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Preclinical CRO Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Details
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Preclinical CRO Treatment Introduction
11.1.4 Charles River Laboratories Revenue in Preclinical CRO Treatment Business (2018-2024)
11.1.5 Charles River Laboratories Recent Developments
11.2 Laboratory Corporation of America
11.2.1 Laboratory Corporation of America Company Details
11.2.2 Laboratory Corporation of America Business Overview
11.2.3 Laboratory Corporation of America Preclinical CRO Treatment Introduction
11.2.4 Laboratory Corporation of America Revenue in Preclinical CRO Treatment Business (2018-2024)
11.2.5 Laboratory Corporation of America Recent Developments
11.3 Envigo
11.3.1 Envigo Company Details
11.3.2 Envigo Business Overview
11.3.3 Envigo Preclinical CRO Treatment Introduction
11.3.4 Envigo Revenue in Preclinical CRO Treatment Business (2018-2024)
11.3.5 Envigo Recent Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Preclinical CRO Treatment Introduction
11.4.4 Eurofins Scientific Revenue in Preclinical CRO Treatment Business (2018-2024)
11.4.5 Eurofins Scientific Recent Developments
11.5 PRA Health Science
11.5.1 PRA Health Science Company Details
11.5.2 PRA Health Science Business Overview
11.5.3 PRA Health Science Preclinical CRO Treatment Introduction
11.5.4 PRA Health Science Revenue in Preclinical CRO Treatment Business (2018-2024)
11.5.5 PRA Health Science Recent Developments
11.6 Wuxi Apptec Co.,Ltd.
11.6.1 Wuxi Apptec Co.,Ltd. Company Details
11.6.2 Wuxi Apptec Co.,Ltd. Business Overview
11.6.3 Wuxi Apptec Co.,Ltd. Preclinical CRO Treatment Introduction
11.6.4 Wuxi Apptec Co.,Ltd. Revenue in Preclinical CRO Treatment Business (2018-2024)
11.6.5 Wuxi Apptec Co.,Ltd. Recent Developments
11.7 Medpace
11.7.1 Medpace Company Details
11.7.2 Medpace Business Overview
11.7.3 Medpace Preclinical CRO Treatment Introduction
11.7.4 Medpace Revenue in Preclinical CRO Treatment Business (2018-2024)
11.7.5 Medpace Recent Developments
11.8 Pharmaceutical Product Development
11.8.1 Pharmaceutical Product Development Company Details
11.8.2 Pharmaceutical Product Development Business Overview
11.8.3 Pharmaceutical Product Development Preclinical CRO Treatment Introduction
11.8.4 Pharmaceutical Product Development Revenue in Preclinical CRO Treatment Business (2018-2024)
11.8.5 Pharmaceutical Product Development Recent Developments
11.9 Paraxel
11.9.1 Paraxel Company Details
11.9.2 Paraxel Business Overview
11.9.3 Paraxel Preclinical CRO Treatment Introduction
11.9.4 Paraxel Revenue in Preclinical CRO Treatment Business (2018-2024)
11.9.5 Paraxel Recent Developments
11.10 Pharmaron
11.10.1 Pharmaron Company Details
11.10.2 Pharmaron Business Overview
11.10.3 Pharmaron Preclinical CRO Treatment Introduction
11.10.4 Pharmaron Revenue in Preclinical CRO Treatment Business (2018-2024)
11.10.5 Pharmaron Recent Developments
11.11 Joinn Laboratories
11.11.1 Joinn Laboratories Company Details
11.11.2 Joinn Laboratories Business Overview
11.11.3 Joinn Laboratories Preclinical CRO Treatment Introduction
11.11.4 Joinn Laboratories Revenue in Preclinical CRO Treatment Business (2018-2024)
11.11.5 Joinn Laboratories Recent Developments
11.12 Medicilon Inc.
11.12.1 Medicilon Inc. Company Details
11.12.2 Medicilon Inc. Business Overview
11.12.3 Medicilon Inc. Preclinical CRO Treatment Introduction
11.12.4 Medicilon Inc. Revenue in Preclinical CRO Treatment Business (2018-2024)
11.12.5 Medicilon Inc. Recent Developments
11.13 Crown Bioscience
11.13.1 Crown Bioscience Company Details
11.13.2 Crown Bioscience Business Overview
11.13.3 Crown Bioscience Preclinical CRO Treatment Introduction
11.13.4 Crown Bioscience Revenue in Preclinical CRO Treatment Business (2018-2024)
11.13.5 Crown Bioscience Recent Developments
11.14 Yinuosi Bio-Technology
11.14.1 Yinuosi Bio-Technology Company Details
11.14.2 Yinuosi Bio-Technology Business Overview
11.14.3 Yinuosi Bio-Technology Preclinical CRO Treatment Introduction
11.14.4 Yinuosi Bio-Technology Revenue in Preclinical CRO Treatment Business (2018-2024)
11.14.5 Yinuosi Bio-Technology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Preclinical CRO Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Bioanalysis and DMPK Studies
Table 3. Key Players of Toxicology Testing
Table 4. Global Preclinical CRO Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Preclinical CRO Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Preclinical CRO Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Preclinical CRO Treatment Market Share by Region (2018-2024)
Table 8. Global Preclinical CRO Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Preclinical CRO Treatment Market Share by Region (2024-2029)
Table 10. Preclinical CRO Treatment Market Trends
Table 11. Preclinical CRO Treatment Market Drivers
Table 12. Preclinical CRO Treatment Market Challenges
Table 13. Preclinical CRO Treatment Market Restraints
Table 14. Global Preclinical CRO Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Preclinical CRO Treatment Revenue Share by Players (2018-2024)
Table 16. Global Top Preclinical CRO Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical CRO Treatment as of 2022)
Table 17. Global Preclinical CRO Treatment Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Preclinical CRO Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Preclinical CRO Treatment, Headquarters and Area Served
Table 20. Global Key Players of Preclinical CRO Treatment, Product and Application
Table 21. Global Key Players of Preclinical CRO Treatment, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Preclinical CRO Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Preclinical CRO Treatment Revenue Market Share by Type (2018-2024)
Table 25. Global Preclinical CRO Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Preclinical CRO Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global Preclinical CRO Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Preclinical CRO Treatment Revenue Share by Application (2018-2024)
Table 29. Global Preclinical CRO Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Preclinical CRO Treatment Revenue Share by Application (2024-2029)
Table 31. North America Preclinical CRO Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Preclinical CRO Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Preclinical CRO Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Preclinical CRO Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Preclinical CRO Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Preclinical CRO Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Preclinical CRO Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Preclinical CRO Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Preclinical CRO Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Preclinical CRO Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Preclinical CRO Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Preclinical CRO Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Preclinical CRO Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Preclinical CRO Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Preclinical CRO Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Preclinical CRO Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Preclinical CRO Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Preclinical CRO Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Preclinical CRO Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Preclinical CRO Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Preclinical CRO Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Preclinical CRO Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Preclinical CRO Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Preclinical CRO Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Preclinical CRO Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Preclinical CRO Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Preclinical CRO Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Preclinical CRO Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Preclinical CRO Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Preclinical CRO Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Preclinical CRO Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Preclinical CRO Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 63. Charles River Laboratories Company Details
Table 64. Charles River Laboratories Business Overview
Table 65. Charles River Laboratories Preclinical CRO Treatment Product
Table 66. Charles River Laboratories Revenue in Preclinical CRO Treatment Business (2018-2024) & (US$ Million)
Table 67. Charles River Laboratories Recent Developments
Table 68. Laboratory Corporation of America Company Details
Table 69. Laboratory Corporation of America Business Overview
Table 70. Laboratory Corporation of America Preclinical CRO Treatment Product
Table 71. Laboratory Corporation of America Revenue in Preclinical CRO Treatment Business (2018-2024) & (US$ Million)
Table 72. Laboratory Corporation of America Recent Developments
Table 73. Envigo Company Details
Table 74. Envigo Business Overview
Table 75. Envigo Preclinical CRO Treatment Product
Table 76. Envigo Revenue in Preclinical CRO Treatment Business (2018-2024) & (US$ Million)
Table 77. Envigo Recent Developments
Table 78. Eurofins Scientific Company Details
Table 79. Eurofins Scientific Business Overview
Table 80. Eurofins Scientific Preclinical CRO Treatment Product
Table 81. Eurofins Scientific Revenue in Preclinical CRO Treatment Business (2018-2024) & (US$ Million)
Table 82. Eurofins Scientific Recent Developments
Table 83. PRA Health Science Company Details
Table 84. PRA Health Science Business Overview
Table 85. PRA Health Science Preclinical CRO Treatment Product
Table 86. PRA Health Science Revenue in Preclinical CRO Treatment Business (2018-2024) & (US$ Million)
Table 87. PRA Health Science Recent Developments
Table 88. Wuxi Apptec Co.,Ltd. Company Details
Table 89. Wuxi Apptec Co.,Ltd. Business Overview
Table 90. Wuxi Apptec Co.,Ltd. Preclinical CRO Treatment Product
Table 91. Wuxi Apptec Co.,Ltd. Revenue in Preclinical CRO Treatment Business (2018-2024) & (US$ Million)
Table 92. Wuxi Apptec Co.,Ltd. Recent Developments
Table 93. Medpace Company Details
Table 94. Medpace Business Overview
Table 95. Medpace Preclinical CRO Treatment Product
Table 96. Medpace Revenue in Preclinical CRO Treatment Business (2018-2024) & (US$ Million)
Table 97. Medpace Recent Developments
Table 98. Pharmaceutical Product Development Company Details
Table 99. Pharmaceutical Product Development Business Overview
Table 100. Pharmaceutical Product Development Preclinical CRO Treatment Product
Table 101. Pharmaceutical Product Development Revenue in Preclinical CRO Treatment Business (2018-2024) & (US$ Million)
Table 102. Pharmaceutical Product Development Recent Developments
Table 103. Paraxel Company Details
Table 104. Paraxel Business Overview
Table 105. Paraxel Preclinical CRO Treatment Product
Table 106. Paraxel Revenue in Preclinical CRO Treatment Business (2018-2024) & (US$ Million)
Table 107. Paraxel Recent Developments
Table 108. Pharmaron Company Details
Table 109. Pharmaron Business Overview
Table 110. Pharmaron Preclinical CRO Treatment Product
Table 111. Pharmaron Revenue in Preclinical CRO Treatment Business (2018-2024) & (US$ Million)
Table 112. Pharmaron Recent Developments
Table 113. Joinn Laboratories Company Details
Table 114. Joinn Laboratories Business Overview
Table 115. Joinn Laboratories Preclinical CRO Treatment Product
Table 116. Joinn Laboratories Revenue in Preclinical CRO Treatment Business (2018-2024) & (US$ Million)
Table 117. Joinn Laboratories Recent Developments
Table 118. Medicilon Inc. Company Details
Table 119. Medicilon Inc. Business Overview
Table 120. Medicilon Inc. Preclinical CRO Treatment Product
Table 121. Medicilon Inc. Revenue in Preclinical CRO Treatment Business (2018-2024) & (US$ Million)
Table 122. Medicilon Inc. Recent Developments
Table 123. Crown Bioscience Company Details
Table 124. Crown Bioscience Business Overview
Table 125. Crown Bioscience Preclinical CRO Treatment Product
Table 126. Crown Bioscience Revenue in Preclinical CRO Treatment Business (2018-2024) & (US$ Million)
Table 127. Crown Bioscience Recent Developments
Table 128. Yinuosi Bio-Technology Company Details
Table 129. Yinuosi Bio-Technology Business Overview
Table 130. Yinuosi Bio-Technology Preclinical CRO Treatment Product
Table 131. Yinuosi Bio-Technology Revenue in Preclinical CRO Treatment Business (2018-2024) & (US$ Million)
Table 132. Yinuosi Bio-Technology Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preclinical CRO Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Preclinical CRO Treatment Market Share by Type: 2022 VS 2029
Figure 3. Bioanalysis and DMPK Studies Features
Figure 4. Toxicology Testing Features
Figure 5. Global Preclinical CRO Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Preclinical CRO Treatment Market Share by Application: 2022 VS 2029
Figure 7. Biopharmaceutical Companies Case Studies
Figure 8. Government and Academic Institutes Case Studies
Figure 9. Medical Device Companies Case Studies
Figure 10. Preclinical CRO Treatment Report Years Considered
Figure 11. Global Preclinical CRO Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Preclinical CRO Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Preclinical CRO Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global Preclinical CRO Treatment Market Share by Players in 2022
Figure 15. Global Top Preclinical CRO Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical CRO Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Preclinical CRO Treatment Revenue in 2022
Figure 17. North America Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Preclinical CRO Treatment Market Share by Type (2018-2029)
Figure 19. North America Preclinical CRO Treatment Market Share by Application (2018-2029)
Figure 20. North America Preclinical CRO Treatment Market Share by Country (2018-2029)
Figure 21. United States Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Preclinical CRO Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Preclinical CRO Treatment Market Share by Type (2018-2029)
Figure 25. Europe Preclinical CRO Treatment Market Share by Application (2018-2029)
Figure 26. Europe Preclinical CRO Treatment Market Share by Country (2018-2029)
Figure 27. Germany Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Preclinical CRO Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Preclinical CRO Treatment Market Share by Type (2018-2029)
Figure 35. China Preclinical CRO Treatment Market Share by Application (2018-2029)
Figure 36. Asia Preclinical CRO Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Preclinical CRO Treatment Market Share by Type (2018-2029)
Figure 38. Asia Preclinical CRO Treatment Market Share by Application (2018-2029)
Figure 39. Asia Preclinical CRO Treatment Market Share by Region (2018-2029)
Figure 40. Japan Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Preclinical CRO Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Preclinical CRO Treatment Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Preclinical CRO Treatment Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Preclinical CRO Treatment Market Share by Country (2018-2029)
Figure 50. Brazil Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Preclinical CRO Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Charles River Laboratories Revenue Growth Rate in Preclinical CRO Treatment Business (2018-2024)
Figure 57. Laboratory Corporation of America Revenue Growth Rate in Preclinical CRO Treatment Business (2018-2024)
Figure 58. Envigo Revenue Growth Rate in Preclinical CRO Treatment Business (2018-2024)
Figure 59. Eurofins Scientific Revenue Growth Rate in Preclinical CRO Treatment Business (2018-2024)
Figure 60. PRA Health Science Revenue Growth Rate in Preclinical CRO Treatment Business (2018-2024)
Figure 61. Wuxi Apptec Co.,Ltd. Revenue Growth Rate in Preclinical CRO Treatment Business (2018-2024)
Figure 62. Medpace Revenue Growth Rate in Preclinical CRO Treatment Business (2018-2024)
Figure 63. Pharmaceutical Product Development Revenue Growth Rate in Preclinical CRO Treatment Business (2018-2024)
Figure 64. Paraxel Revenue Growth Rate in Preclinical CRO Treatment Business (2018-2024)
Figure 65. Pharmaron Revenue Growth Rate in Preclinical CRO Treatment Business (2018-2024)
Figure 66. Joinn Laboratories Revenue Growth Rate in Preclinical CRO Treatment Business (2018-2024)
Figure 67. Medicilon Inc. Revenue Growth Rate in Preclinical CRO Treatment Business (2018-2024)
Figure 68. Crown Bioscience Revenue Growth Rate in Preclinical CRO Treatment Business (2018-2024)
Figure 69. Yinuosi Bio-Technology Revenue Growth Rate in Preclinical CRO Treatment Business (2018-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries